159 related articles for article (PubMed ID: 9074536)
1. Effect of specific activity on cardiac uptake of iodine-123-MIBG.
Farahati J; Bier D; Scheubeck M; Lassmann M; Schelper LF; Grelle I; Hanscheid H; Biko J; Graefe KH; Reiners C
J Nucl Med; 1997 Mar; 38(3):447-51. PubMed ID: 9074536
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo studies with no-carrier added radioiodinated MIBG.
Franceschini R; Pecorale A; Chinol M; Calcagni ML; Servidei T; Riccardi R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):72-7. PubMed ID: 9002755
[TBL] [Abstract][Full Text] [Related]
3. No-carrier-added iodine-131-MIBG: evaluation of a therapeutic preparation.
Mairs RJ; Cunningham SH; Russell J; Armour A; Owens J; McKellar K; Gaze MN
J Nucl Med; 1995 Jun; 36(6):1088-95. PubMed ID: 7769433
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
[TBL] [Abstract][Full Text] [Related]
5. Improved labelling of no-carrier-added 123I-MIBG and preliminary clinical evaluation in patients with ventricular arrhythmias.
Samnick S; Bader JB; Müller M; Chapot C; Richter S; Schaefer A; Sax B; Kirsch CM
Nucl Med Commun; 1999 Jun; 20(6):537-45. PubMed ID: 10451866
[TBL] [Abstract][Full Text] [Related]
6. Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
Vaidyanathan G; Affleck DJ; Zalutsky MR
J Nucl Med; 1995 Apr; 36(4):644-50. PubMed ID: 7699460
[TBL] [Abstract][Full Text] [Related]
7. Effects of extrinsically elevated plasma norepinephrine concentration on myocardial 123I-MIBG kinetics in rats.
Shouda S; Kurata C; Mikami T; Wakabayashi Y
J Nucl Med; 1999 Dec; 40(12):2088-93. PubMed ID: 10616890
[TBL] [Abstract][Full Text] [Related]
8. Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts--implications for clinical studies.
Dae MW; De Marco T; Botvinick EH; O'Connell JW; Hattner RS; Huberty JP; Yuen-Green MS
J Nucl Med; 1992 Aug; 33(8):1444-50. PubMed ID: 1634934
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats.
Kiyono Y; Iida Y; Kawashima H; Ogawa M; Tamaki N; Nishimura H; Saji H
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):999-1005. PubMed ID: 12173012
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
[TBL] [Abstract][Full Text] [Related]
11. Effect of specific activity on organ uptake of iodine-123-meta-iodobenzylguanidine in humans.
Farahati J; Lassmann M; Scheubeck M; Bier D; Hanscheid H; Schelper L; Grelle I; Biko J; Werner E; Graefe K; Reiners C
Int J Oncol; 1997 Apr; 10(4):815-9. PubMed ID: 21533450
[TBL] [Abstract][Full Text] [Related]
12. [Serial change of 123I-metaiodobenzylguanidine (MIBG) myocardial concentration in patients with dilated cardiomyopathy].
Yamakado K; Takeda K; Kitano T; Nakagawa T; Futagami Y; Konishi T; Hamada M; Nakano T; Ichihara T
Kaku Igaku; 1990 Jul; 27(7):703-8. PubMed ID: 2232338
[TBL] [Abstract][Full Text] [Related]
13. Clinical evaluation of no-carrier-added meta-[123I]iodobenzylguanidine for myocardial scintigraphy.
Knickmeier M; Matheja P; Wichter T; Schäfers KP; Kies P; Breithardt G; Schober O; Schäfers M
Eur J Nucl Med; 2000 Mar; 27(3):302-7. PubMed ID: 10774882
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous assessment of regional adrenergic activity and perfusion with 123I-MIBG and 201Tl in congestive heart failure.
Seto H; Shimizu M; Nozawa T; Yoshida N; Inagaki S; Kageyama M; Kakishita M
Nucl Med Commun; 1996 Mar; 17(3):225-30. PubMed ID: 8692490
[TBL] [Abstract][Full Text] [Related]
15. Myocardial iodine-123-metaiodobenzylguanidine images and autonomic nerve activity in normal subjects.
Morozumi T; Kusuoka H; Fukuchi K; Tani A; Uehara T; Matsuda S; Tsujimura E; Ito Y; Hori M; Kamada T; Nishimura T
J Nucl Med; 1997 Jan; 38(1):49-52. PubMed ID: 8998149
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy--Clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography.
Yamazaki J; Muto H; Kabano T; Yamashina S; Nanjo S; Inoue A
Am Heart J; 2001 Apr; 141(4):645-52. PubMed ID: 11275933
[TBL] [Abstract][Full Text] [Related]
17. Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity.
Verberne HJ; Sokole EB; van Moerkerken AF; Deeterink JH; Ensing G; Stabin MG; Somsen GA; van Eck-Smit BL
Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):798-807. PubMed ID: 18183394
[TBL] [Abstract][Full Text] [Related]
18. Myocardial uptake of meta-[123I]-iodobenzylguanidine [( 123I]-MIBG) in patients with myocardial infarct.
Fagret D; Wolf JE; Comet M
Eur J Nucl Med; 1989; 15(9):624-8. PubMed ID: 2574671
[TBL] [Abstract][Full Text] [Related]
19. Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients.
Schnell O; Muhr D; Weiss M; Dresel S; Haslbeck M; Standl E
Diabetes; 1996 Jun; 45(6):801-5. PubMed ID: 8635656
[TBL] [Abstract][Full Text] [Related]
20. Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies.
Somsen GA; Borm JJ; Dubois EA; Schook MB; Van Der Wall EE; Van Royen EA
Nucl Med Commun; 1996 Oct; 17(10):872-6. PubMed ID: 8951908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
